Terms: = Breast cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 AND Staging
3 results:
1. Contribution of ABCB1 and cyp2d6 genotypes to the outcome of tamoxifen adjuvant treatment in premenopausal women with breast cancer.
Argalácsová S; Slanař O; Vítek P; Tesařová P; Bakhouche H; DraŽďáková M; Bartošová O; Zima T; PertuŽelka L
Physiol Res; 2015; 64(Suppl 4):S539-47. PubMed ID: 26681084
[TBL] [Abstract] [Full Text] [Related]
2. Effect of cyp2d6 polymorphisms on breast cancer recurrence.
Morrow PK; Serna R; Broglio K; Pusztai L; Nikoloff DM; Hillman GR; Fontecha M; Li R; Michaud L; Hortobagyi G; Gonzalez-Angulo AM
Cancer; 2012 Mar; 118(5):1221-7. PubMed ID: 21823108
[TBL] [Abstract] [Full Text] [Related]
3. Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples.
Rae JM; Cordero KE; Scheys JO; Lippman ME; Flockhart DA; Johnson MD
Pharmacogenetics; 2003 Aug; 13(8):501-7. PubMed ID: 12893988
[TBL] [Abstract] [Full Text] [Related]